Theraputic Goods ACT 1989
I, Michael Wiseman, Head, Medicines Authorisation Branch, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health for the purposes of section 42 DK (1) of the Therapeutic Goods Act, give notice that the restricted representations described in paragraph (a) below, being representations that are necessary for the appropriate use of the therapeutic goods described in paragraph (b) below, may be included either on the label of the package of the goods or in information included in the package in which those goods are contained:
- Representations to the effect that the goods described in paragraph (b) below may be used to 'For the treatment of patients with known cardiovascular or cerebrovascular disease an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke)'
- TERRY WHITE CHEMISTS EC ASPIRIN 100 aspirin 100 mg enteric-coated tablet blister pack (new formulation) (AUST R 238412)
- supplied as an over-the-counter medicine.
Dated this 29th day of June 2015
Signed electronically
Michael Wiseman
Delegate of the Secretary to the Department of Health; and
Head, Medicines Authorisation Branch